Journal article · 2024 · Open access

Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns

Adeera Levin, Sofia Bano Ahmed, Juan Jesús Carrero, Bethany Joy Foster, Anna Francis, Rasheeda K. Hall, William Guy Herrington, Guy Hill, Lesley A. Inker, Rümeyza Kazancıoğlu, Edmund J. Lamb, Peter Lin and 21 more

Kidney International, 105(4), 684–701 · Published 20 March 2024 · DOI 10.1016/j.kint.2023.10.016

Read the free full textCite this paper

In brief

“Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns” is a 2024 journal article by Adeera Levin and 32 co-authors, published in Kidney International. OpenAlex counts 516 citations as of 15 November 2026, which puts it in the top 1% of works published in 2024 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Kidney International.

Citations
516
Most cited in
2026 (274)
Field-weighted impact
127.12
References
24
Authors
33

Abstract

The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology. This update, based on a substantially broader base of evidence than has previously been available, reflects an exciting time in nephrology. New therapies and strategies have been tested in large and diverse populations that help to inform care; however, this guideline is not intended for people receiving dialysis nor those who have a kidney transplant. The document is sensitive to international considerations, CKD across the lifespan, and discusses special considerations in implementation. The scope includes chapters dedicated to the evaluation and risk assessment of people with CKD, management to delay CKD progression and its complications, medication management and drug stewardship in CKD, and optimal models of CKD care. Treatment approaches and actionable guideline recommendations are based on systematic reviews of relevant studies and appraisal of the quality of the evidence and the strength of recommendations which followed the "Grading of Recommendations Assessment, Development, and Evaluation" (GRADE) approach. The limitations of the evidence are discussed. The guideline also provides practice points, which serve to direct clinical care or activities for which a systematic review was not conducted, and it includes useful infographics and describes an important research agenda for the future. It targets a broad audience of people with CKD and their healthcare, while being mindful of implications for policy and payment.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Levin, A., Ahmed, S. B., Carrero, J. J., Foster, B. J., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., Lamb, E. J., Lin, P., Madero, M., McIntyre, N. J., Morrow, K. J., Roberts, G. V., Sabanayagam, D., Schäeffner, E., Shlipak, M. G., . . . Stevens, P. E. (2024). Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kidney International, 105(4), 684–701. https://doi.org/10.1016/j.kint.2023.10.016

MLA 9

Levin, Adeera, et al. “Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.” Kidney International, vol. 105, no. 4, 2024, pp. 684–701. https://doi.org/10.1016/j.kint.2023.10.016.

Chicago

Levin, Adeera, Sofia Bano Ahmed, Juan Jesús Carrero, Bethany Joy Foster, Anna Francis, Rasheeda K. Hall, William Guy Herrington, et al. 2024. “Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.” Kidney International 105 (4): 684–701. https://doi.org/10.1016/j.kint.2023.10.016.

Harvard

Levin, A. et al. (2024) ‘Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns’, Kidney International, 105(4), pp. 684–701. doi:10.1016/j.kint.2023.10.016.

IEEE

A. Levin et al., “Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns,” Kidney International, vol. 105, no. 4, pp. 684–701, 2024, doi: 10.1016/j.kint.2023.10.016.

BibTeX

@article{levin2024executive,
  title     = {{Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns}},
  author    = {Levin, Adeera and Ahmed, Sofia Bano and Carrero, Juan Jesús and Foster, Bethany Joy and Francis, Anna and Hall, Rasheeda K. and Herrington, William Guy and Hill, Guy and Inker, Lesley A. and Kazancıoğlu, Rümeyza and Lamb, Edmund J. and Lin, Peter and Madero, Magdalena and McIntyre, Natasha J. and Morrow, Kelly J. and Roberts, Glenda V. and Sabanayagam, Dharshana and Schäeffner, Elke and Shlipak, Michael G. and Shroff, Rukshana C. and Tangri, Navdeep and Thanachayanont, Teerawat and Ulasi, Ifeoma and Wong, Germaine and Yang, Chih‐Wei and Zhang, Luxia and Robinson, Karen A. and Wilson, Lisa M and Wilson, Renée F and Kasiske, B.L. and others},
  journal   = {Kidney International},
  year      = {2024},
  volume    = {105},
  number    = {4},
  pages     = {684--701},
  doi       = {10.1016/j.kint.2023.10.016},
  url       = {https://doi.org/10.1016/j.kint.2023.10.016}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20245151
2025191191
2026274274

Its field-weighted citation impact is 127.12: it has been cited 127.12 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes

  • chronic kidney disease
  • KDIGO guidelines
  • chronic kidney disease progression
  • CKD complications
  • research agenda

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Levin, A., Ahmed, S. B., Carrero, J. J., Foster, B. J., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., Lamb, E. J., Lin, P., Madero, M., McIntyre, N. J., Morrow, K. J., Roberts, G. V., Sabanayagam, D., Schäeffner, E., Shlipak, M. G., . . . Stevens, P. E. (2024). Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kidney International, 105(4), 684–701. https://doi.org/10.1016/j.kint.2023.10.016

How many times has this paper been cited?

516 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Kidney International.

Who wrote this paper?

Adeera Levin, Sofia Bano Ahmed, Juan Jesús Carrero, Bethany Joy Foster, Anna Francis, Rasheeda K. Hall, William Guy Herrington, Guy Hill, Lesley A. Inker, Rümeyza Kazancıoğlu, Edmund J. Lamb, Peter Lin and 21 more.

What is the DOI of this paper?

10.1016/j.kint.2023.10.016. The permanent link is https://doi.org/10.1016/j.kint.2023.10.016.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.